• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

diabetes

Dexcom focuses on early diabetes diagnosis as COVID links emerge

June 29, 2022 By Jim Hammerand

New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s […]

Filed Under: Blog, Diabetes, Featured, News Well Tagged With: CGM, coronavirus, covid, COVID-19, Dexcom, diabetes

MIT team working on all-in-one diabetes management devices

January 20, 2022 By Sean Whooley

MIT researchers are touting a platform aimed at helping patients maintain healthy glucose levels by streamlining the diabetes management process. The MIT researchers say it’s hard for people with diabetes to maintain a treatment regimen. Typically at every meal, they need to estimate carbohydrate content, draw blood to measure blood glucose levels, and calculate the […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Patient Monitoring, Research & Development Tagged With: diabetes, mit

Walmart teams up with Novo Nordisk to launch private-brand analog insulin 

June 30, 2021 By Brian Buntz

Walmart (NYSE:WMT) is launching what it describes as the first private label analog insulin. The company estimates the insulin products will save customers between 58% and 70% of the cost of branded insulin. Novo Nordisk (NYSE:NVO) will manufacture the analog insulin, which is a type of lab-grown insulin genetically engineered to optimize glucose control. The […]

Filed Under: Blog, Diabetes, Featured Tagged With: analog insulin, diabetes, FlexPen, insulin, Novo Nordisk, Walmart

Study shows CGMs better at controlling blood sugar in type 2 diabetes

June 3, 2021 By Sean Whooley

Kaiser Permanente is touting a study demonstrating that using continuous glucose monitors offers better blood sugar control for patients with type 2 diabetes. Patients with insulin-treated type 2 diabetes using continuous glucose monitors (CGMs) typically had better blood sugar control and fewer visits to the emergency room for hypoglycemia, the study found. The study was […]

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring Tagged With: CGM, Dexcom, diabetes, Kaiser Permanente

FDA issues draft clinical trial guidelines for neurostim, other devices to treat diabetes

May 19, 2021 By Sean Whooley

The FDA today issued a draft guidance with recommendations for clinical trials for certain devices intended for treating diabetes. Included in the guidance are recommendations for feasibility and early feasibility clinical studies for certain medical devices intended to therapeutically improve glycemic control in patients with type 2 diabetes mellitus, independent of medication delivery, according to […]

Filed Under: Bioelectronic Medicine, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Neurological, Neuromodulation/Neurostimulation, Regulatory/Compliance Tagged With: diabetes, FDA

Insulet shares down after Q1 miss

May 7, 2021 By Brian Buntz

Insulet (NSDQ:PODD) stock is down today — a day after the wearable insulin delivery system developer posted break-even Q1 results that were lower than analysts’ expectations. The company, however, yesterday evening raised the low end of its revenue guidance range to 16–20%. The range was previously 15–20%. The Acton, Mass.-based company a net loss of […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: diabetes, Insulet

Once-a-week insulin dosing shows promise in studies

April 19, 2021 By Sean Whooley

Studies suggest that a new once-per-week injectable insulin therapy is safe and as effective as daily injections for those with type 2 diabetes. Two international clinical trials published today in Diabetes Care found that the once-weekly treatment has the potential to offer a convenient alternative to daily insulin shots for those with type 2 diabetes, according […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured Tagged With: diabetes, Novo Nordisk

Virta Health touts study of treatment preventing progression to Type 2 diabetes

March 2, 2021 By Sean Whooley

Virta Health announced today that a study of its diabetes progression prevention treatment proved more effective than initially expected. Peer-reviewed research in Nutrients highlighted the fact that only 3% of trial participants progressed to Type 2 diabetes, while over half achieved prediabetes reversal during the first two years, according to a news release. Get the full story at […]

Filed Under: Clinical Trials, Diabetes, Featured Tagged With: diabetes, Virta Health

Why COVID-19 could drive a surge in diabetes

February 2, 2021 By Brian Buntz

Diabetes was already an epidemic before the novel coronavirus struck. But some researchers now suspect that COVID-19 can trigger the condition. Approximately 14% of patients with severe COVID-19 develop the disease, according to a meta-analysis recently published in the journal Diabetes, Obesity and Metabolism. To arrive at that thesis, the researchers analyzed eight studies. Half of […]

Filed Under: Diabetes Tagged With: COVID-19, diabetes

How CGMs can inspire lifestyle changes

January 27, 2021 By Brian Buntz

As an early adopter of fitness trackers such as the Fitbit, I’ve long appreciated the power of health data. But my recent experience with a continuous glucose monitor (CGM) has done far more to inspire me to look after my health — even as a nondiabetic. I had heard about the potential of such technology […]

Filed Under: Diabetes, Digital Health, Featured Tagged With: blood glucose, Dexcom, diabetes, Digital Health, G6

How continuous glucose monitors have transformed the diabetes landscape

January 25, 2021 By Brian Buntz

Continuous glucose monitors (CGMs) are among the most potent diabetes management tools to emerge in recent decades. FDA approved the first professional CGM in 1999, and the technology has evolved swiftly since then. Current models beam data via Bluetooth to smartphones (plus the Apple Watch) and the cloud, enabling patients to explore their blood glucose […]

Filed Under: Blog, Diabetes, Digital Health, Drug Pumps, Drug-Device Combinations, Featured Tagged With: A1C, blood glucose, blood glucose monitoring, CDC, CGM, continuous glucose monitor, diabetes, fingerstick, hypoglycemia, smartphone

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS